IT1261776B - Uso di terbinafina per il trattamento terapeutico della pneumocistosi. - Google Patents

Uso di terbinafina per il trattamento terapeutico della pneumocistosi.

Info

Publication number
IT1261776B
IT1261776B ITRM930154A ITRM930154A IT1261776B IT 1261776 B IT1261776 B IT 1261776B IT RM930154 A ITRM930154 A IT RM930154A IT RM930154 A ITRM930154 A IT RM930154A IT 1261776 B IT1261776 B IT 1261776B
Authority
IT
Italy
Prior art keywords
terbinafina
pneumocystosis
therapeutic treatment
pneumopathy
terbinafine
Prior art date
Application number
ITRM930154A
Other languages
English (en)
Inventor
Simone Claudio De
Original Assignee
Mendes Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mendes Srl filed Critical Mendes Srl
Publication of ITRM930154A0 publication Critical patent/ITRM930154A0/it
Priority to ITRM930154A priority Critical patent/IT1261776B/it
Priority to ES94910517T priority patent/ES2178650T3/es
Priority to JP6519792A priority patent/JPH08508012A/ja
Priority to DE69430867T priority patent/DE69430867T2/de
Priority to PT94910517T priority patent/PT692963E/pt
Priority to PCT/IT1994/000023 priority patent/WO1994020082A1/en
Priority to AT94910517T priority patent/ATE219667T1/de
Priority to KR1019950703775A priority patent/KR100343031B1/ko
Priority to DK94910517T priority patent/DK0692963T3/da
Priority to EP94910517A priority patent/EP0692963B1/en
Priority to US08/525,526 priority patent/US5719192A/en
Priority to CA002157590A priority patent/CA2157590C/en
Publication of ITRM930154A1 publication Critical patent/ITRM930154A1/it
Application granted granted Critical
Publication of IT1261776B publication Critical patent/IT1261776B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/08—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis for Pneumocystis carinii

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Uso di terbinafina per la profilassi primaria e secondaria ed il trattamento della pneumopatia da Pneumocystis carinii, comprendente la somministrazione, ad un soggetto affetto da tale pneumopatia, di 3-20 mg/kg/die di terbinafina per os.
ITRM930154A 1993-03-12 1993-03-12 Uso di terbinafina per il trattamento terapeutico della pneumocistosi. IT1261776B (it)

Priority Applications (12)

Application Number Priority Date Filing Date Title
ITRM930154A IT1261776B (it) 1993-03-12 1993-03-12 Uso di terbinafina per il trattamento terapeutico della pneumocistosi.
AT94910517T ATE219667T1 (de) 1993-03-12 1994-03-11 Verwendung von terbinafin zur behandlung von pneumocystosis
DK94910517T DK0692963T3 (da) 1993-03-12 1994-03-11 Anvendelse af terbinafin til terapeutisk behandling af pneumocystose
DE69430867T DE69430867T2 (de) 1993-03-12 1994-03-11 Verwendung von terbinafin zur behandlung von pneumocystosis
PT94910517T PT692963E (pt) 1993-03-12 1994-03-11 Utilizacao da terbinafina para o tratamento terapeutico da pneumocistose
PCT/IT1994/000023 WO1994020082A1 (en) 1993-03-12 1994-03-11 Use of terbinafine for the therapeutic treatment of pneumocystosis
ES94910517T ES2178650T3 (es) 1993-03-12 1994-03-11 Uso de terbinafina para el tratamiento terapeutico de neumocitosis.
KR1019950703775A KR100343031B1 (ko) 1993-03-12 1994-03-11 간질형질세포성폐렴의치료방법을위한테르비나핀의사용
JP6519792A JPH08508012A (ja) 1993-03-12 1994-03-11 ニューモシスチス症の治療のためのテルビナフィンの使用
EP94910517A EP0692963B1 (en) 1993-03-12 1994-03-11 Use of terbinafine for the therapeutic treatment of pneumocystosis
US08/525,526 US5719192A (en) 1993-03-12 1994-03-11 Use of terbinafine for the therapeutic treatment of pneumocystosis
CA002157590A CA2157590C (en) 1993-03-12 1994-03-11 Use of terbinafine for the therapeutic treatment of pneumocystosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM930154A IT1261776B (it) 1993-03-12 1993-03-12 Uso di terbinafina per il trattamento terapeutico della pneumocistosi.

Publications (3)

Publication Number Publication Date
ITRM930154A0 ITRM930154A0 (it) 1993-03-12
ITRM930154A1 ITRM930154A1 (it) 1994-09-12
IT1261776B true IT1261776B (it) 1996-06-03

Family

ID=11401596

Family Applications (1)

Application Number Title Priority Date Filing Date
ITRM930154A IT1261776B (it) 1993-03-12 1993-03-12 Uso di terbinafina per il trattamento terapeutico della pneumocistosi.

Country Status (12)

Country Link
US (1) US5719192A (it)
EP (1) EP0692963B1 (it)
JP (1) JPH08508012A (it)
KR (1) KR100343031B1 (it)
AT (1) ATE219667T1 (it)
CA (1) CA2157590C (it)
DE (1) DE69430867T2 (it)
DK (1) DK0692963T3 (it)
ES (1) ES2178650T3 (it)
IT (1) IT1261776B (it)
PT (1) PT692963E (it)
WO (1) WO1994020082A1 (it)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0003360D0 (en) 2000-02-14 2000-04-05 Novartis Ag Monoclonal antibodies
GB0014448D0 (en) * 2000-06-13 2000-08-09 Novartis Ag Organic compounds
US7244703B2 (en) * 2001-06-22 2007-07-17 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for peptide treatment
US7112561B2 (en) 2003-12-08 2006-09-26 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for insulin treatment

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9111611D0 (en) * 1991-05-30 1991-07-24 Sandoz Ltd Liposomes

Also Published As

Publication number Publication date
EP0692963A1 (en) 1996-01-24
ITRM930154A0 (it) 1993-03-12
ITRM930154A1 (it) 1994-09-12
KR960700699A (ko) 1996-02-24
WO1994020082A1 (en) 1994-09-15
ATE219667T1 (de) 2002-07-15
CA2157590C (en) 2006-01-10
KR100343031B1 (ko) 2002-11-07
DK0692963T3 (da) 2002-10-14
JPH08508012A (ja) 1996-08-27
PT692963E (pt) 2002-10-31
US5719192A (en) 1998-02-17
DE69430867D1 (de) 2002-08-01
EP0692963B1 (en) 2002-06-26
ES2178650T3 (es) 2003-01-01
DE69430867T2 (de) 2003-01-02
CA2157590A1 (en) 1994-09-15

Similar Documents

Publication Publication Date Title
AR052921A1 (es) Uso de ranolazina para la preparacion de una composicion farmaceutica y composicion farmaceutica
AR037109A1 (es) Uso de flibanserina
BR9407250A (pt) Uso de uma droga tendo atividade vasodilatadora para a fabricação de um medicamento para administração transmucosal transdérmica intranasal e retal
ES2172533T3 (es) Uso de nonapeptidos y decapeptidos para la preparacion de un medicamento para combatir el sida.
ATE435294T1 (de) Verabreichung von biologisch aktiven polypeptiden
DE50211204D1 (de) Cannabis extrakten pharmazeutische zusammensetzung
HUP0104318A2 (hu) cGMP PDE-5 inhibitort tartalmazó szabályzottan hatóanyagot felszabadító gyógyászati készítmények
TR200000369T2 (tr) Romatizmal hastalıkların tedavisinde kullanılmak üzere kombine farmasötik preparatların üretilmesi.
DK1071439T3 (da) Hybenformuleringer som antiinflammatorisk naturmedicin til lindring/reduktion af symptomer associeret med inflammation og artritis
GB2323088A (en) Indane dimer compounds and their pharmaceutical use
HK1068606A1 (en) Novel aminobenzoephenones
IT1255723B (it) Uso di paratormone,suoi frammenti biologicamente attivi e peptidi correlati, per la preparazione di composizioni farmaceutiche utili nella prevenzione e terapia dell'aborto e del parto pretermine ed in generale per il trattamento della gestazione
ES2147788T3 (es) 3,4-diarilcromanos para el tratamiento de la dermatitis.
AR019699A1 (es) Composicion farmaceutica para el tratamiento de disfuncion de la evacuacion y uso de la misma para la preparacion de un agente terapeutico
AR015744A1 (es) Uso de dexmedetomidina para sedacion en terapia intensiva
IT1261776B (it) Uso di terbinafina per il trattamento terapeutico della pneumocistosi.
BG108452A (en) Tablet comprising cetirizine and pseudoephedrine
ATE311928T1 (de) (-)-pseudoephedrin als sympathomimetisches arzneimittel
TR199800765T2 (xx) Otoim�n hastal�klar�n tedavisine mahsus bir farmas�tik bile�im
HUP9901659A2 (hu) Flupirtin alkalmazása a hematopoetikus sejtrendszer károsodásával kapcsolatos megbetegedések megelőzésére és gyógyítására alkalmas gyógyszerkészítmény előállítására
AR059965A2 (es) Uso de 8,9-dehidroestrona para la preparacion de un medicamento antioxidante
ITRM950544A0 (it) Uso della l-carnitina di suoi derivati e di loro sali farmaceuticamen-te accettabili in combinazione con farmaci antiretrovirali per ridurrei livelli di ceramide e potenziare l'attivita' di tali farmaci antire-trovirali per il trattamento terapeutico dell'invenzione...
CO5070598A1 (es) Kit anticonceptivo que comprende medios para la administra- cion diaria de un agente anticonceptivo unico que es un com- puesto esteroide que combina las actividades progestagenica y estrogenica
AR007058A1 (es) Uso de interferon en medicamentos y composiciones para contacto oromucosal
HUP9800623A2 (hu) (+)-O-demetil-tramadol felhasználása fájdalomcsillapító hatású orális gyógyszerkészítmények előállítására

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970227